Patents by Inventor Eriko OKA

Eriko OKA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of producing immunotherapy vaccine
    Patent number: 11642402
    Abstract: A method of producing an immunotherapy vaccine is provided. The method includes performing a heat treatment to exosomes separated from cancer cells or body fluids including blood of a cancer patient to promote inactivation of proteolytic enzymes in the exosomes, and introducing or co-culturing the exosomes in dendritic cells derived from blood of the cancer patient or a healthy person to make antigen-presenting cells.
    Type: Grant
    Filed: September 3, 2020
    Date of Patent: May 9, 2023
    Assignees: CYTIX INC., KINKO CAPITAL CO.. LTD.
    Inventors: Sadatoshi Sakuma, Michiyo Osono, Eriko Oka
  • DENDRITIC CELL-BASED CANCER VACCINES AND PREPARATION METHOD THEREOF
    Publication number: 20220233603
    Abstract: The present invention is directed to methods for preparing a recombinant cell and a fusion cell for a dendritic cell-based cancer vaccine, wherein the recombinant cell and the fusion cell comprise DNA of a cancer cell. The present invention is also directed to the fusion cells comprising genomic DNA of a tumor cell, a method for fusing human dendritic cells and fibroblast cells, a pharmaceutical composition comprising the fusion cell, and a method of preventing cancer comprising administering to a cancer patient an effective amount of the fusion cells.
    Type: Application
    Filed: May 27, 2019
    Publication date: July 28, 2022
    Inventors: Sadatoshi SAKUMA, Michiyo OSONO, Futoshi ISHIKAWA, Toshiki UOZUMI, Eriko OKA, Hiroki MURATA, Hui Yu YANG
  • METHOD OF PRODUCING IMMUNOTHERAPY VACCINE
    Publication number: 20210069311
    Abstract: A method of producing an immunotherapy vaccine is provided. The method includes performing a heat treatment to exosomes separated from cancer cells or body fluids including blood of a cancer patient to promote inactivation of proteolytic enzymes in the exosomes, and introducing or co-culturing the exosomes in dendritic cells derived from blood of the cancer patient or a healthy person to make antigen-presenting cells.
    Type: Application
    Filed: September 3, 2020
    Publication date: March 11, 2021
    Inventors: Sadatoshi SAKUMA, Michiyo OSONO, Eriko OKA